Interim Results of AirXpanders’ Multi-Centered Randomized Controlled Trial Demonstrate Faster, Needle-Free Alternative to Saline Tissue Expanders

Interim Results of AirXpanders’ Multi-Centered Randomized Controlled Trial Demonstrate Faster, Needle-Free Alternative to Saline Tissue Expanders   Highly statistically significant improvement in expansion and total implant times compared to saline Interim results of the XPAND trial published in the April … Continue reading

Share

AeroForm Approved in Australia

World’s First Needle-Free, Patient-Controlled Tissue Expansion Device for Women Undergoing Breast Reconstruction Following Mastectomy Approved in Australia  Australia represents the first commercial market for AirXpanders’s AeroForm®  Company to launch AeroForm to select plastic surgeons  PALO ALTO, Calif. (November 4, 2013) … Continue reading

Share

XPAND and PACE Results

AirXpanders Announces Preliminary Results from Two Clinical Studies That Show Breast Reconstruction Patients Completed Tissue Expansion with AeroForm™ Patient-Controlled Tissue Expander in 17 Days on Average Traditional saline expansion for breast reconstruction after mastectomy often requires up to six months … Continue reading

Share